Russo, G.L. ; Sonsalla, G. ; Natarajan, P. ; Breunig, C. ; Bulli, G. ; Merl-Pham, J. ; Schmitt, S.* ; Giehrl-Schwab, J. ; Giesert, F. ; Jastroch, M.* ; Zischka, H. ; Wurst, W. ; Stricker, S.H. ; Hauck, S.M. ; Masserdotti, G. ; Götz, M.
     
 
    
        
         CRISPR-mediated induction of neuron-enriched mitochondrial proteins boosts direct glia-to-neuron conversion.
        CRISPR-mediated induction of neuron-enriched mitochondrial proteins boosts direct glia-to-neuron conversion.
     
    
        
    
    
        
        Cell Stem Cell 28, 524-534.e7 (2021)
    
    
    
		
		
			
				Astrocyte-to-neuron conversion is a promising avenue for neuronal 
replacement therapy. Neurons are particularly dependent on mitochondrial
 function, but how well mitochondria adapt to the new fate is unknown. 
Here, we determined the comprehensive mitochondrial proteome of cortical
 astrocytes and neurons, identifying about 150 significantly enriched 
mitochondrial proteins for each cell type, including transporters, 
metabolic enzymes, and cell-type-specific antioxidants. Monitoring their
 transition during reprogramming revealed late and only partial 
adaptation to the neuronal identity. Early dCas9-mediated activation of 
genes encoding mitochondrial proteins significantly improved conversion 
efficiency, particularly for neuron-enriched but not astrocyte-enriched 
antioxidant proteins. For example, Sod1 not only improves the survival 
of the converted neurons but also elicits a faster conversion pace, 
indicating that mitochondrial proteins act as enablers and drivers in 
this process. Transcriptional engineering of mitochondrial proteins with
 other functions improved reprogramming as well, demonstrating a broader
 role of mitochondrial proteins during fate conversion.
    
    
  
			 
			
				
			
		 
		
			
				
					
					Impact Factor
					Scopus SNIP
					Web of Science
Times Cited
					Scopus
Cited By
					
					Altmetric
					
				 
				
			 
		 
		
     
    
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Wissenschaftlicher Artikel
    
 
    
        Typ der Hochschulschrift
        
    
 
    
        Herausgeber
        
    
    
        Schlagwörter
        CRISPR-a; antioxidant; direct reprogramming; metabolism; mitochondria; proteome; Glutamate Carrier Slc25a22; Cell Identity; Stem; Identification; Proteome; Encephalopathy; Metabolism; Mechanisms; Astrocytes; Mutation
    
 
    
        Keywords plus
        
    
 
    
    
        Sprache
        englisch
    
 
    
        Veröffentlichungsjahr
        2021
    
 
    
        Prepublished im Jahr 
        2020
    
 
    
        HGF-Berichtsjahr
        2020
    
 
    
    
        ISSN (print) / ISBN
        1934-5909
    
 
    
        e-ISSN
        1875-9777
    
 
    
        ISBN
        
    
 
    
        Bandtitel
        
    
 
    
        Konferenztitel
        
    
 
	
        Konferzenzdatum
        
    
     
	
        Konferenzort
        
    
 
	
        Konferenzband
        
    
 
     
		
    
        Quellenangaben
        
	    Band: 28,  
	    Heft: 3,  
	    Seiten: 524-534.e7 
	    Artikelnummer: ,  
	    Supplement: ,  
	
    
 
  
        
            Reihe
            
        
 
        
            Verlag
            Cell Press
        
 
        
            Verlagsort
            Cambridge, Mass.
        
 
	
        
            Tag d. mündl. Prüfung
            0000-00-00
        
 
        
            Betreuer
            
        
 
        
            Gutachter
            
        
 
        
            Prüfer
            
        
 
        
            Topic
            
        
 
	
        
            Hochschule
            
        
 
        
            Hochschulort
            
        
 
        
            Fakultät
            
        
 
    
        
            Veröffentlichungsdatum
            0000-00-00
        
 
         
        
            Anmeldedatum
            0000-00-00
        
 
        
            Anmelder/Inhaber
            
        
 
        
            weitere Inhaber
            
        
 
        
            Anmeldeland
            
        
 
        
            Priorität
            
        
 
    
        Begutachtungsstatus
        Peer reviewed
    
 
     
    
        POF Topic(s)
        30204 - Cell Programming and Repair
30203 - Molecular Targets and Therapies
    
 
    
        Forschungsfeld(er)
        Stem Cell and Neuroscience
Enabling and Novel Technologies
Genetics and Epidemiology
    
 
    
        PSP-Element(e)
        G-500800-001
G-505700-001
G-500500-001
G-505200-003
    
 
    
        Förderungen
        SPP2127
AMPro Project (Aging and Metabolic Programming) network funds of the Helmholtz Association
SyNergy-HMGU
ERAnet
advanced ERC ChroNeuroRepair
German Research Foundation
Fondation Rodger de Spoelberch
    
 
    
        Copyright
        
    
 	
    
    
    
    
    
        Erfassungsdatum
        2020-12-10